-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Hengrui Medicine and Iktos of France signed a strategic cooperation agreement on AI new drug development platform
Makya™ developed by Iktos is an artificial intelligence-driven generative de novo small molecule drug design software that can be used for multi-parameter optimization (MPO)
Dr.
"We are very happy to cooperate with Hengrui, a leading global pharmaceutical company from China
Founded in October 2016, Iktos is a start-up company specializing in the development of artificial intelligence solutions for medicinal chemistry and new drug design